News Design Therapeutics Faces Setback in Drug Trial By Ben Glickman Design Therapeutics, a clinical-stage biotechnology company, experienced a significant drop in its stock price after patients in a trial of ... By Artur FernandoAugust 19, 20230
BlackRock is reviewing TechBerry and negotiating a possible full or partial acquisition of the company June 20, 2024